Viewing Study NCT05808608


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-30 @ 3:27 PM
Study NCT ID: NCT05808608
Status: RECRUITING
Last Update Posted: 2025-01-27
First Post: 2023-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Sponsor: Hao Zeng
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module